To The Moon

$Robo.ai Inc(AIIO)$ AIIO took a hard hit yesterday, no doubt. But one red session doesn't erase the progress on the business side. With September revenue surpassing $100M and management targeting around $600M for 2026, there's still a growth story worth following. Short-term volatility is tough, but the bigger picture deserves attention too.

Medline Inc. stands at the core of the global healthcare delivery infrastructure, operating as both a premier manufacturer and a dominant distributor of medical-surgical products. Having completed one of the largest initial public offerings in recent healthcare history in late 2025, raising $6.26 billion at an initial valuation near $37 billion, the company has transitioned into a high-profile public asset. Currently trading around $36.26 per share with a market capitalization of roughly $47 billion, Medline represents a critical operational backbone for health systems, surgical centres, and long-term care facilities. Despite short-term share price volatility stemming from post-IPO operational adjustments and debt service costs, Medline’s vast scale, vertical integration, and impressive to

$Robo.ai Inc(AIIO)$ Robo.ai reframed its hardware assets as connected nodes within a broader AI, IoT, and Machine Economy ecosystem.